Related Experiment Videos
Human fungal pathogens accelerate into the genomics era
1Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB24 2ZD, UK. m.straffon@abdn.ac.uk
Genome Biology
|December 12, 2001
Abstract:
A report on the Euroconference on Fungal Virulence Factors and Disease: 'Human Fungal Pathogens', Seefeld, Austria, 8-13 September 2001.
Insights
This report summarizes the 2001 Euroconference on Fungal Virulence Factors and Disease, focusing on human fungal pathogens. Key discussions covered virulence mechanisms and disease pathogenesis in mycology.
Area of Science:
- Medical Mycology
- Pathogen Biology
Background:
- The 2001 Euroconference convened experts to discuss fungal virulence factors and human fungal pathogens.
- This meeting highlighted the growing importance of understanding fungal pathogenesis for human health.
Framework:
- The conference focused on mechanisms of fungal invasion and host-pathogen interactions.
- Discussions addressed the molecular basis of fungal virulence and disease development.
Implementation:
- Presentations covered a range of human fungal pathogens, including Candida and Aspergillus species.
- Research highlighted novel diagnostic and therapeutic strategies against fungal infections.
Implications:
- Advances in understanding fungal virulence factors are crucial for developing effective antifungal therapies.
- Continued research into human fungal pathogens is essential for public health and clinical management.